Twist Bioscience Corp (NAS:TWST)
$ 46.39 -0.69 (-1.47%) Market Cap: 2.72 Bil Enterprise Value: 2.52 Bil PE Ratio: 0 PB Ratio: 5.53 GF Score: 85/100

Q4 2021 Twist Bioscience Corp Earnings and to Discuss Acquisition of Abveris Inc Call Transcript

Nov 22, 2021 / 01:00PM GMT
Release Date Price: $98.17 (-11.25%)
Operator

Good day. Welcome to Twist Biosciences Fiscal 2021 Fourth Quarter and Full Year Financial Results Conference Call. (Operator Instructions) As a reminder, this call is being recorded.

I would now like to turn the call over to Angela Bitting, SVP of Corporate Affairs and Chief ESG Officer. You may begin.

Angela Bitting
Twist Bioscience Corporation - Chief ESG Officer & Senior VP of Corporate Affairs

Thank you, Michelle. Good morning, everyone. I would like to thank all of you for joining us today for Twist Biosciences conference call to review our fiscal 2021 fourth quarter and full year financial results and business progress.

We issued our financial results release as well as the press release announcing we entered into an agreement to acquire Abveris this morning, both of which are available at our website at www.twistbioscience.com.

With me on today's call are Dr. Emily Leproust, CEO and Co-Founder of Twist; and Jim Thorburn, CFO of Twist. Emily will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot